TABLE 2.
Number of subjects with paired results available for quantitative analyses for each strain and each studya
| Strain | No. of subjected with indicated results |
|||||
|---|---|---|---|---|---|---|
| Study 1 |
Study 2 |
|||||
| TIVc | TIVe | Total | aQIV | QIV | Total | |
| A/H1N1 | 1,002 | 323 | 1,325 | ND | ND | ND |
| A/H3N2 | 1,004 | 325 | 1,329 | 1,036 | 1,020 | 2,056 |
| B | 1,004 | 325 | 1,329 | 1,070 | 1,041 | 2,111 |
a
Abbreviations: aQIV, adjuvanted quadrivalent influenza vaccine; ND, not determined; QIV, nonadjuvanted quadrivalent influenza vaccine; TIVc, cell-derived trivalent influenza vaccine; TIVe, egg-derived trivalent influenza vaccine.